Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: Nuclear translocation of androgen receptor complex with β-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors

Endocrinology

Volumn 147, Issue 1, 2006, Pages 141-154

  Singh, Rajan ^a   Artaza, Jorge N ^a   Taylor, Wayne E ^a   Braga, Melissa ^a   Yuan, Xin ^b   Gonzalez Cadavid, Nestor F ^a   Bhasin, Shalender ^a,c  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; BETA CATENIN; BICALUTAMIDE; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN DELTA; COMPLEMENTARY DNA; ETOPOSIDE; FLUTAMIDE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; T CELL FACTOR PROTEIN; T CELL GROWTH FACTOR 4; TESTOSTERONE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WNT1 PROTEIN;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL STRAIN 3T3; CONTROLLED STUDY; CULTURE MEDIUM; DOMINANT INHERITANCE; DOWN REGULATION; GENE ACTIVATION; GENE CONSTRUCT; GENETIC TRANSFECTION; HORMONE INHIBITION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

3T3 CELLS; ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; CELL NUCLEUS; GENE EXPRESSION REGULATION; MICE; PROTEIN TRANSPORT; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TESTOSTERONE; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; WNT PROTEINS;

EID: 29344440814     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2004-1649     Document Type: Article

References (52)

1. Mauras N, Hayes V, Welch S, Rini A, Helgeson K, Dokler M, Veldhuis JD, Urban RJ 1998 Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab 83:1886-1892
2. Matsumoto T, Takeyama K, Sato T, Kato S 2003 Androgen receptor functions from reverse genetic models. J Steroid Biochem Mol Biol 85:95-99
3. Wilson JD 1988 Androgen abuse by athletes. Endocr Rev 9:181-191
4. Bhasin S, Woodhouse L, Casaburi R, Singh AB, Bhasin D, Berman N, Chen X, Yarasheski KE, Magliano L, Dzekov C, Dzekov J, Bross R, Phillips J, Sinha-Hikim I, Shen R, Storer TW 2001 Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 281:E1172-E1181
5. Snyder PJ, Peachey H, Berlin JA, Hannoush P, Haddad G, Dlewati A, Santanna J, Loh L, Lenrow DA, Holmes JH, Kapoor S, Atkinson L, Strom S 2000 Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 85:2670-2677
6. Bhasin S, Storer TW, Berman N, Yarasheski KE, Clevenger B, Phillips J, Lee WP, Bunnell TJ, Casaburi R 1997 Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab 82:407-413
7. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L Lenrow DA, Holmes JH, Dlewati A, Santanna J, Rosen CJ, Strom BL 1999 Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 84:2647-2653
8. Bhasin S, Storer TW, Javanbakht M, Berman, N, Yarasheski KE, Phillips J, Dike M, Sinha-Hikim I, Shen R, Hays RD, Beall G 2000 Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. JAMA 283:763-778
9. Grinspoon S, Corcoran C, Askari H, Schoenfeld D, Wolf L, Burrows B, Walsh M, Hayden D, Parlman K, Anderson E, Basgoz N, Klibanski A 1998 Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double blind, placebo-controlled trial. Ann Intern Med 129:18-26
10. Garcia E, Lacasa M, Agli B, Giudicelli Y, Lacasa D 1999 Modulation of rat preadipocyte adipose conversion by androgenic status: involvement of C/EBPs transcription factors. J Endocrinol 161:89-97
11. Dieudonne MN, Pecquery R, Leneveu MC, Giudicelli Y 2000 Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor-γ2. Endocrinology 141:649-656
12. Ramirez ME, McMurry MP, Wiebke GA, Felten KJ, Ren K, Meikle AW, Iverius PH 1997 Evidence for sex steroid inhibition of lipoprotein lipase in men: comparison of abdominal and femoral adipose tissue. Metabolism 46:179-185
13. Brodsky IG, Balagopal P, Nair KS 1996 Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men: a clinical research center study. J Clin Endocrinol Metab 81:3469-3475
14. Marin P, Holmang S, Jonsson, L Sjostrom L, Kvist H, Holm G, Lindstedt G, Bjorntorp P 1992 The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 16:991-997
15. Marin P, Oden B, Bjorntorp P 1995 Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab 80:239-243
16. Marin P, Krotkiewski M, Bjorntorp P 1992 Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues. Eur J Med 1:329-336
17. Dieudonne MN, Pecquery R, Boumediene A, Lenevew MC, Giudicelli Y 1998 Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. Am J Physiol 274:C1645-C1652
18. Jaubert AM, Pecquery R, Sichez L, Dieudonne MN, Cloix JF, Giudicelli Y 1993 Androgen receptors in hamster white adipocytes and their precursor cells: regional variations and modulation by androgens. Endocrine 1:535-540
19. Mooradian AD, Morley JE, Korenman SG 1987 Biological actions of androgens. Endocr Rev 8:1-28
20. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM 1995 The nuclear receptor superfamily: the second decade. Cell 83:835-839
21. Singh R, Artaza JN, Taylor WE, Gonzalez-Cadavid NF, Bhasin S 2003 Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 44:5081-5088
22. Yeh S, Tsai M-Y, Xu Q, Mu XM, Lardy H, Huang KE, Lin H, Yeh SD, Altuwaijri S, Zhou X, Xing L, Boyce BF, Hung MC, Zhang S, Gan L, Chang C, Hung MC 2002 Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proc Natl Acad Sci USA 99:13498-13503
23. Mulholland DJ, Cheng H, Reid K, Rennie PS, Nelson CC 2002 The androgen receptor can promote β-catenin nuclear translocation independently of adenomatous polyposis coli. J Biol Chem 277:17933-17943
24. Pawlowski JE, Ertel JR, Allen MP, Xu M, Butler C, Wilson EM, Wierman ME 2002 Liganded androgen receptor interaction with β-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cells. J Biol Chem 277:20702-20710
25. Yang F, Li X, Sharma, M, Sasaki CY, Longo DL, Lim B, Sun Z 2002 Linking β-catenin to androgen-signaling pathway. J Biol Chem 277:11336-11344
26. Truica CI, Byers S, Gelmann EP 2000 β-Catenin affects androgen receptor transcriptional activity and ligand specificity. Cancer Res 60:4709-4713
27. Cadigan KM, Nusse R 1997 Wnt signaling: a common theme in animal development. Genes Dev 11:3286-3305
28. Cossu G, Borello U 1999 Wnt signaling and the activation of myogenesis in mammals. EMBO J 24:6867-6872
29. Nelson WJ, Nusse R 2004 Convergence of Wnt, β-catenin, and cadherin pathways. Science 303:1483-1487
30. Yanfeng W, Saint-Jeannet JP, Klein PS 2003 Wnt-frizzled signaling in the induction and differentiation of the neural crest. Bioessays 25:317-325
31. Kawano Y, Kypta R 2003 Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116:2627-2634
32. Polakis P 2000 Wnt signaling and cancer. Genes Dev 14:1837-1851
33. Morin PJ 1999 β-Catenin signaling and cancer. Bioessays 21:1021-1030
34. Longo KA, Wright WS, Kang S, Gerin I, Chiang SH, Lucas PC, Opp MR, MacDougald OA 2004 Wnt10b inhibits development of white and brown adipose tissues. J Biol Chem 279:35503-35509
35. Ross SE, Hemati N, Longo KA, Bebbett CN, Jucas PC, Erickson RL, MacDougald OA 2000 Inhibition of adipogenesis by Wnt signaling. Science 289:950-953
36. Bennet CN, Ross SE, Longo KA, Bajnok L, Hemati N, Johnson KW, Harrison SD, MacDougald OA 2002 Regulation of Wnt signaling during adipogenesis. J Biol Chem 277:30998-31004
37. Gregoire FM, Smas CA, Sul HS 1998 Understanding adipocyte differentiation. Physiol Rev 78:783-808
38. Rosen ED, Hsu C-H, Wang X, Sakai S, Freeman MW, Gonzalez FJ, Spigelman BM 2002 C/EBP-α induces adipogenesis through PPARγ: a unified pathway. Genes Dev 16:22-26
39. Green H, Kehinde O 1976 Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell 1:105-113
40. Lu S, Liu M, Epner DE, Tsai SY, Tsai MJ 1999 Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter. Mol Endocrinol 13:376-384
41. Hemati N, Ross SE, Erickson RL, Groblewski GE, MacDougald OA 1997 Signaling pathways through which insulin regulates CCAAT/enhancer binding protein-α (C/EBP-α) phosphorylation and gene expression in 3T3-L1 adipocytes. Correlation with GLUT4 gene expression. J Biol Chem 272:25913-25919
42. Artaza JN, Bhasin, S, Mallidis C, Taylor W, Ma K, Gonzalez-Cadavid NF 2002 Endogenous expression and localization of myostatin and its relation to myosin heavy chain distribution in C2C12 skeletal muscle cells. J Cell Physiol 190:170-179
43. Bienz M 2002 The subcellular destinations of APC proteins. Nat Rev Mol Cell Biol 3:328-338
44. Fearnhead NS, Britton MP, Bodmer WF 2001 The ABC of APC. Hum Mol Genet 10:721-733
45. Neufeld KL, White RL 1997 Nuclear and cytoplasmic localization of adenomatous polyposis coli protein. Proc Natl Acad Sci USA 94:3034-3039
46. Zhang F, White RL, Neufeld KL 2001 Cell density and phosphorylation control the subcellular localization of adenomatous polyposis coli protein. Mol Cell Biol 21:8143-8156
47. MacDougald OA, Lane MD 1995 Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem 64:345-373
48. Hovanes K, Li TW, Munguia JE, Truong T, Milovanovic T, Lawrence Marsh J, Holcombe RF, Waterman ML 2001 β-Catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet 28:53-57
49. Willert J, Epping M, Pollack JR, Brown PO, Nusse R 2002 A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev Biol 2:8
50. Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R, Clevers H, Pals ST 1999 Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 154:515-523
51. Sui X, Bramlett KS, Jorge MC, Swanson DA, von Eschenbach AC, Jenster G 1999 Specific androgen receptor activation by an artificial coactivator. J Biol Chem 274:9449-9454
52. Yuan X, Lu ML, Li T, Balk SP 2001 SRY interacts with and negatively regulates androgen receptor transcriptional activity. J Biol Chem 276:46647-46654